John Mark O'Mahony - Jan 31, 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Chief Manufacturing Officer
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
Stock symbol
LPTX
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
4
Date filed
2/2/2022, 08:51 PM
Previous filing
May 28, 2021
Next filing
Sep 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Restricted Stock Units Award $0 +225K $0.00 225K Jan 31, 2022 Common Stock 225K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units were awarded pursuant to Leap's 2016 Equity Incentive Plan for no consideration. Restricted Stock Units will be settled in common stock.
F2 The Restricted Stock Units will cliff vest and be settled after three years of continuous service or upon a change of control of Leap, whichever is earlier.